Finasteride Cost in Nebraska 2026

What Does Finasteride Actually Cost in Nebraska Right Now?

Generic finasteride tablets cost an average of $12 per month at Nebraska retail pharmacies in 2026 when paid out of pocket. That figure covers a 30-day supply of 1 mg tablets for androgenetic alopecia (AGA) or 5 mg tablets for benign prostatic hyperplasia (BPH). Brand-name Propecia and Proscar carry list prices near $85 per month, but those brand versions contain the same active molecule at the same approved doses, so most clinicians and pharmacists will substitute the generic automatically.

Price variation across Nebraska cities is real. A GoodRx-verified cash price in Omaha for finasteride 1 mg (30 tablets) ranges from $9 to $18 depending on pharmacy chain. Lincoln pharmacies cluster in a similar band. Rural Nebraska pharmacy networks may run slightly higher, typically $14 to $20, because independent pharmacies carry lower dispensing volume and qualify for fewer manufacturer rebates [1].

Finasteride belongs to the 5-alpha reductase inhibitor class. It blocks the conversion of testosterone to dihydrotestosterone (DHT), the androgen responsible for follicular miniaturization in genetically susceptible men and for prostate enlargement [2]. The FDA approved the 5 mg formulation (Proscar) for BPH in 1992 and the 1 mg formulation (Propecia) for AGA in 1997 [3]. Generic versions became widely available after patent expiration, which is the primary reason cash prices dropped to current levels.

For context on efficacy, Kaufman et al. (1998, N=1,553) demonstrated that finasteride 1 mg once daily produced statistically significant increases in hair count and hair weight compared with placebo over 48 weeks, with 83% of treated men maintaining or improving hair count versus 28% in the placebo group (P<0.001) [4]. That trial remains the most-cited controlled efficacy dataset for this drug at the 1 mg dose.

Nebraska Medicaid Coverage for Finasteride

Nebraska Medicaid does not cover finasteride for androgenetic alopecia. The state's preferred drug list classifies AGA treatment as cosmetic, placing it outside covered indications regardless of the prescribing provider's documentation. Coverage for the 5 mg BPH indication is also excluded on the standard Nebraska Medicaid formulary as of the 2026 plan year [5].

This contrasts with some Midwest state Medicaid programs that do cover finasteride 5 mg for BPH under prior authorization. Nebraska's exclusion is consistent with its broader policy of treating 5-alpha reductase inhibitors for BPH as non-preferred without a documented failure of behavioral management or alpha-blocker therapy first. Even when providers submit prior authorization requests citing AUA BPH guidelines, approval rates remain low under the current formulary structure [6].

Dual-eligible beneficiaries enrolled in a Medicare Part D plan may have a different experience. Part D formularies set coverage independently. A 2024 CMS formulary analysis found that roughly 60% of Part D standalone prescription drug plans covered finasteride 5 mg for BPH, typically in Tier 1 or Tier 2 with a $0 to $10 copay [7]. Nebraska residents on Medicare should check their specific plan's Summary of Benefits and Coverage for 2026.

The table below provides a practical coverage decision framework for Nebraska patients and prescribers:

| Situation | Coverage Status | Next Step | |---|---|---| | Nebraska Medicaid, AGA | Not covered | Cash-pay or GoodRx coupon | | Nebraska Medicaid, BPH | Not covered as preferred | Prior auth; low approval rate | | Medicare Part D, BPH | Varies by plan; ~60% cover | Check plan formulary | | Employer PPO/HMO, AGA | Usually not covered | Appeal with clinical notes | | Employer PPO/HMO, BPH | Often Tier 1 or 2 | Submit with ICD-10 N40.x |

Which Insurance Plans Cover Finasteride in Nebraska?

Private insurance coverage for finasteride in Nebraska depends entirely on whether the diagnosis is BPH or AGA, and on the specific plan formulary. For BPH, most commercial PPO and HMO plans list generic finasteride 5 mg as a Tier 1 preferred generic, with copays of $0 to $15 per month after the deductible is met [8]. The ICD-10 code N40.1 (BPH with lower urinary tract symptoms) triggers coverage most reliably; N40.0 (without symptoms) may be questioned during utilization review.

For AGA, commercial insurance routinely classifies the condition as cosmetic and excludes coverage. Some plans will cover finasteride 5 mg off-label for AGA if the prescriber documents a therapeutic substitution rationale, though this approach requires splitting a 5 mg tablet into quarters, a practice that is pharmacologically sound because finasteride 5 mg tablets are scored, but many insurers flag it as off-label use and deny the claim regardless [9].

Nebraska's state employee health plans, administered through the University of Nebraska system and the State of Nebraska Group Insurance, follow standard commercial formulary logic. Finasteride 5 mg for BPH is typically covered. For AGA, coverage is absent across all three major state employee plan tiers as of the 2026 benefits guide.

Appealing a denial for AGA requires submitting a letter of medical necessity that cites psychological burden data. A 2022 study in the Journal of the American Academy of Dermatology found that AGA is associated with significantly higher rates of depression and anxiety (OR 1.71 to 95% CI 1.54 to 1.90) compared with matched controls [10]. Including that evidence in an appeal does not guarantee approval but provides clinical grounding that a simple prescription note cannot.

Is Compounded Finasteride Legal in Nebraska?

Compounded finasteride is legal in Nebraska when prepared by a licensed 503A pharmacy. A 503A pharmacy is a state-licensed compounding pharmacy that operates under Section 503A of the Federal Food, Drug, and Cosmetic Act and compounds medications for individual patients based on a valid prescription [11]. Nebraska's Department of Health and Human Services oversees pharmacy licensure and requires that 503A compounders meet USP standards for non-sterile preparations, which covers oral finasteride capsules and any topical formulations.

Compounded finasteride is not interchangeable with FDA-approved Propecia or Proscar from a regulatory standpoint. The FDA has not verified the bioavailability, stability, or sterility of compounded versions, and compounded drugs are not required to carry FDA-approved labeling [12]. That distinction matters clinically: patients switching from brand or generic to a compounded formulation should understand that the pharmacokinetic profile may differ based on the excipients used.

Pricing for compounded finasteride through Nebraska 503A pharmacies runs approximately $45 per month. That is above the $12 cash-pay generic price at retail chains but below the $85 brand list price. Compounded options are most relevant for patients who need a dose not commercially available (for example, 0.5 mg for low-dose protocols), who require a topical formulation for those who wish to minimize systemic DHT suppression, or who are using finasteride as part of a broader hormone-related treatment program that a compounding pharmacy coordinates [13].

The American Hair Loss Association notes that topical finasteride formulations have gained interest because early data suggest lower systemic DHT suppression compared with oral administration. A 2019 randomized trial (N=323) published in JAMA Dermatology found that topical finasteride 0.25% solution applied once daily achieved comparable hair density outcomes to oral finasteride 1 mg over 24 weeks while producing smaller reductions in serum DHT [14]. Nebraska patients interested in topical formulations will need a 503A compounding pharmacy, as no topical finasteride is commercially approved in the United States as of 2026.

Can You Get Finasteride via Telehealth in Nebraska?

Nebraska permits telehealth prescribing of finasteride. A licensed prescriber holding a Nebraska DEA registration (or a license to practice in Nebraska for non-scheduled drugs) may evaluate a patient via synchronous audio-video visit and issue a finasteride prescription without an in-person examination, provided the standard of care for that evaluation is met [15]. Finasteride is not a controlled substance, so the federal Ryan Haight Act's in-person visit requirement does not apply.

The Nebraska Department of Health and Human Services codified telehealth prescribing authority under Neb. Rev. Stat. Section 71-8505, which requires that telehealth services meet the same standard of care as in-person services. In practice, this means a prescriber evaluating a patient for AGA via telehealth should review a relevant history, assess contraindications (notably pregnancy exposure risk and prior prostate cancer history), and document the clinical rationale before prescribing [16].

Telehealth platforms operating in Nebraska that offer finasteride typically charge a monthly subscription of $20 to $35, which often includes both the clinical visit fee and the medication. When those platforms dispense generic finasteride directly, the all-in cost can be competitive with or below the retail cash-pay price of $12 for the tablet alone, because the platform negotiates volume pricing with dispensing pharmacies. Patients should confirm that the prescribing clinician holds an active Nebraska license and that the dispensing pharmacy is licensed in Nebraska before enrolling.

What Is the Cheapest Way to Get Finasteride in Nebraska?

The cheapest widely accessible option is generic finasteride purchased with a discount coupon at a high-volume retail pharmacy. GoodRx, RxSaver, and similar platforms aggregate pharmacy pricing and generate coupons that pharmacies accept in lieu of insurance. With a coupon, the $12 average cash price can fall to $8 to $10 at Walmart, Costco, or Kroger-affiliated pharmacies in Omaha or Lincoln [17].

A few additional strategies reduce cost further. Walmart's $4/$10 generic drug program lists finasteride 5 mg in Nebraska stores as of 2026, covering a 30-day or 90-day supply for $4 or $10 respectively. The 1 mg dose is not on that specific list, so patients using the 5 mg tablet and splitting it for AGA benefit more from this program than those seeking the 1 mg tablet directly. Costco pharmacy members in Nebraska consistently rank among the lowest-price dispensers for a 90-day supply [18].

Manufacturer savings programs are a secondary option. Merck's Propecia savings card, available through the branded drug's official site, reduces out-of-pocket cost for commercially insured patients who still want brand Propecia. The card typically covers the gap between insurance copay and $35 per fill for eligible patients, but it does not apply to Medicaid or Medicare beneficiaries [19]. Because the generic performs identically, most clinicians see no clinical reason to pursue the brand savings card over simply using the generic.

For patients managing finasteride as part of a testosterone replacement or broader hormonal protocol, bundling the prescription through a telehealth platform that handles multiple medications under one dispensing arrangement often yields the best per-medication cost. Some Nebraska-accessible platforms offer finasteride as a $0 add-on when it is prescribed alongside another medication.

Finasteride Safety Profile: What Nebraska Patients Should Know Before Starting

Finasteride's side effect profile is well-characterized across large trial populations. The most discussed risks involve sexual function. In the Prostate Cancer Prevention Trial (PCPT, N=18,882), finasteride 5 mg daily over 7 years was associated with sexual side effects in approximately 8.2% of participants versus 5.7% in the placebo arm [20]. At the 1 mg AGA dose, the original Merck Phase III trials reported erectile dysfunction in 1.3% of treated men versus 0.7% in the placebo group [3].

Post-finasteride syndrome is a reported clinical entity in which sexual, neurological, and psychological symptoms persist after stopping the drug. The FDA added a label update in 2012 acknowledging reports of persistent sexual dysfunction following discontinuation [21]. The absolute incidence remains debated in the literature; a 2020 systematic review in JAMA Dermatology (21 studies analyzed) could not establish a reliable prevalence estimate because of heterogeneous outcome definitions across studies, but the authors acknowledged the condition as clinically real in a subset of patients [22].

Women who are pregnant or may become pregnant must not handle crushed or broken finasteride tablets. The drug is a Category X teratogen for male fetal genitalia. Intact tablets are film-coated and safe to handle, but any formulation that exposes the active ingredient (crushed tablets, topical preparations) carries fetal risk from dermal absorption [3]. Nebraska prescribers using telehealth must document this counseling for any patient in a household with a pregnant partner.

Baseline PSA values matter for men over 50 starting finasteride for BPH. Finasteride reduces PSA by approximately 50% after 6 months of use, which can mask early prostate cancer detection if the clinical team is not aware of the patient's finasteride use [23]. The AUA guideline on BPH management (2021 update) recommends documenting a baseline PSA before initiating 5 mg therapy and using a doubling correction factor for PSA values obtained while on the drug [6].

How to Start Finasteride in Nebraska: A Step-by-Step Summary

Starting finasteride in Nebraska involves four practical steps. First, obtain a prescription from a licensed Nebraska provider, either in person or via a telehealth platform that employs Nebraska-licensed clinicians. Second, confirm your diagnosis code with the prescriber: N40.1 for BPH or L64.9 for AGA, because the code determines whether an insurance claim has any chance of approval. Third, use a pharmacy discount tool to compare prices at retail pharmacies in your zip code before filling; the price spread between the highest and lowest local options can exceed $10 per month. Fourth, set a follow-up visit at 12 months: the AGA efficacy data from Kaufman et al. showed that hair count improvements plateau around month 12, making that visit the appropriate point to assess whether treatment is producing the expected response [4].

Men with BPH should additionally schedule a PSA measurement at 6 months to establish the post-treatment baseline, per AUA recommendations, and recheck annually thereafter [6]. Patients using compounded topical finasteride through a 503A pharmacy should request a certificate of analysis confirming active ingredient concentration and microbial testing results before beginning use [12].